We will review the latest IRA developments, focusing on those aspects directly impacting pharmaceutical pricing and regulatory policies.
Delve into the specific provisions of the IRA that affect drug pricing, examining potential impacts on pricing strategies and overall industry profitability.
Monday September 30, 2024 3:00pm - 3:30pm EDT
Log in to save this to your schedule, view media, leave feedback and see who's attending!
